From Pre-Approval to Post-Launch

End-to-End Commercialization Guide for Specialty Pharma

A practical guide to specialty pharma commercialization: government pricing, patient support programs, specialty pharmacy selection, and post-launch strategy.

Two Labs and Riparian, both part of Envision Pharma Group, work alongside specialty pharma manufacturers at nearly every stage of commercialization — government pricing and compliance, patient support programs, specialty pharmacy selection, trade and distribution, and post-launch optimization.

Each chapter of this guide was written by the experts who lead that work, drawing on real conversations with manufacturers navigating these decisions. Read this guide and you’ll walk into these same decisions with a clearer sense of what works, what tends to go wrong, and where to focus first.

What’s inside:

Download the eBook:

Meet the experts

Will Pih
Co-Founder, Two Labs
Jennifer Lospinoso
President, Riparian
Aimee Bando-Bugosh
VP Patient Services, Two Labs
Anita Dopkosky
Vice President, Commercialization, Two Labs
Emily Campbell
Director of Training, Development, 
and Quality, Two Labs
Meggan Smith
Vice President, Commercialization, Two Labs
Susan Dunne
Managing Director,
Riparian